检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:胡佳贞 张青川[1] 何春锋[1] HU Jia-zhen;ZHANG Qing-chuan;HE Chun-feng(Putuo Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 200062,China)
出 处:《中国实用医药》2020年第3期189-191,共3页China Practical Medicine
基 金:中医大预算内项目(理科)(项目编号:18LK060),项目名称:人参皂苷Rh2介导IL-6/IL-8调控雄激素受体抑制前列腺癌PC3细胞生长的机制研究。
摘 要:前列腺癌(PCa)的发病率持续增长,时严重影响我国老年男性健康的恶性肿瘤。当前列腺癌晚期发生耐药后,现代医学治疗方式尚没有非常显著的效果。在中医药方面,有其独到的缓解病症、减小肿块、延长其生存时间的效果。本篇文章中综述前列腺癌中医辨证分型及中医药治疗的研究现状,为晚期前列腺癌的治疗提供一些新的思路。The incidence of cancer of prostate(PCA)continues to increase,which seriously affects the health of elderly men in China.After drug resistance in advanced stage of adenocarcinoma,modern medical treatment cannot have not yet had a very significant effect.Chinese medicine has its unique effect,such as ease symptoms,shrink tumors,and prolong the survival time.In this paper,the traditional Chinese medicine dialectical classification of cancer of prostate and the research status of traditional Chinese medicine treatment are reviewed,which provides some new ideas for the treatment of advanced cancer of prostate.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.222